These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 18157945

  • 1. Stability of mycophenolic acid and glucuronide metabolites in human plasma and the impact of deproteinization methodology.
    de Loor H, Naesens M, Verbeke K, Vanrenterghem Y, Kuypers DR.
    Clin Chim Acta; 2008 Mar; 389(1-2):87-92. PubMed ID: 18157945
    [Abstract] [Full Text] [Related]

  • 2. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
    Figurski MJ, Korecka M, Fields L, Waligórska T, Shaw LM.
    Ther Drug Monit; 2009 Dec; 31(6):717-26. PubMed ID: 19809389
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography.
    Mino Y, Naito T, Matsushita T, Kagawa Y, Kawakami J.
    J Pharm Biomed Anal; 2008 Feb 13; 46(3):603-8. PubMed ID: 18164890
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
    Shipkova M, Schütz E, Besenthal I, Fraunberger P, Wieland E.
    Ther Drug Monit; 2010 Feb 13; 32(1):79-85. PubMed ID: 20042920
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine.
    Benoit-Biancamano MO, Caron P, Lévesque E, Delage R, Couture F, Guillemette C.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct 15; 858(1-2):159-67. PubMed ID: 17827076
    [Abstract] [Full Text] [Related]

  • 9. Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry.
    Patel CG, Mendonza AE, Akhlaghi F, Majid O, Trull AK, Lee T, Holt DW.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec 25; 813(1-2):287-94. PubMed ID: 15556544
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A high-throughput U-HPLC-MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine.
    Klepacki J, Klawitter J, Bendrick-Peart J, Schniedewind B, Heischmann S, Shokati T, Christians U, Klawitter J.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb 01; 883-884():113-9. PubMed ID: 21839692
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Simultaneous determination of mycophenolic acid and its phenolic glucuronide in human plasma using an isocratic high-performance liquid chromatography procedure.
    Indjova D, Kassabova L, Svinarov D.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar 25; 817(2):327-30. PubMed ID: 15687002
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous determination of mycophenolate and its metabolite mycophenolate-7-o-glucuronide with an isocratic HPLC-UV-based method in human plasma and stability evaluation.
    Rissling O, Bauer S, Shipkova M, Glander P, Mai M, Hambach P, Budde K.
    Scand J Clin Lab Invest; 2016 Dec 25; 76(8):612-619. PubMed ID: 27676419
    [Abstract] [Full Text] [Related]

  • 15. Influence of renal insufficiency on pharmacokinetics of ACYL-glucuronide metabolite of mycophenolic acid in renal transplant patients.
    González-Roncero FM, Govantes MA, Chaves VC, Palomo PP, Serra MB.
    Transplant Proc; 2007 Sep 25; 39(7):2176-8. PubMed ID: 17889129
    [Abstract] [Full Text] [Related]

  • 16. HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material.
    Bolon M, Jeanpierre L, El Barkil M, Chelbi K, Sauviat M, Boulieu R.
    J Pharm Biomed Anal; 2004 Nov 15; 36(3):649-51. PubMed ID: 15522544
    [Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetics of mycophenolic acid and its 2 glucuronidated metabolites in kidney transplant recipients.
    Sam WJ, Akhlaghi F, Rosenbaum SE.
    J Clin Pharmacol; 2009 Feb 15; 49(2):185-95. PubMed ID: 19179297
    [Abstract] [Full Text] [Related]

  • 18. Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites.
    Brandhorst G, Streit F, Goetze S, Oellerich M, Armstrong VW.
    Clin Chem; 2006 Oct 15; 52(10):1962-4. PubMed ID: 16931568
    [Abstract] [Full Text] [Related]

  • 19. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients.
    Mino Y, Naito T, Otsuka A, Ushiyama T, Ozono S, Kagawa Y, Kawakami J.
    Clin Biochem; 2009 May 15; 42(7-8):595-601. PubMed ID: 19100248
    [Abstract] [Full Text] [Related]

  • 20. UPLC MS/MS method for quantification of mycophenolic acid and metabolites in human plasma: Application to pharmacokinetic study.
    Delavenne X, Juthier L, Pons B, Mariat C, Basset T.
    Clin Chim Acta; 2011 Jan 14; 412(1-2):59-65. PubMed ID: 20937266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.